Fauna Herawati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fauna Herawati has a total of 171 co-authors. Here are the top co-authors by number of shared publications:
- Rika Yulia
Department of Clinical Pharmacy, Faculty of Pharmacy, University of Surabaya, Surabaya 60293, Indonesia
23 shared publications Rika Yulia
Departemen Farmasi Klinis, Fakultas Farmasi, Universitas Surabaya
13 shared publications- Kevin Kantono
School of Science, Auckland University of Technology, Private Bag 92006, Auckland 1142, New Zealand
6 shared publications - Marisca Evalina Gondokesumo
University of Surabaya, Indonesia
6 shared publications - Adji Prayitno Setiadi
Universitas Surabaya
5 shared publications Retnosari Andrajati
5 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 9 (2) , 225-234
Analysis of Antibiotic Use in Outpatient Pneumonia Patients at X Blitar Health Center using the Gyssens Method and the Defined Daily Dose
Pneumonia is a respiratory infection that remains a public health problem and requires appropriate antibiotic therapy. However, irrational use of antibiotics has the potential to increase resistance and worsen patient clinical outcomes. This study aims to analyze antibiotic use among outpatient patients with pneumonia at the X Blitar Health Center using the Defined Daily Dose (DDD) and Gyssens methods. This study employed a cross-sectional approach, utilizing secondary data from 109 medical records and prescriptions for pneumonia patients (ICD-10 codes J12-J18) from February 2024 to May 2025. Quantitative analysis was conducted using the DDD per 1,000 patients per day method, while qualitative analysis of prescriptions was performed using the Gyssens method. The results showed that Amoxicillin (J01CA04) was the most widely used antibiotic, namely 232.42 DDD/1,000 patients per day, followed by Cefadroxil (87.04 DDD/1,000 patients per day), Ciprofoxacin (18.35 DDD/1,000 patients per day), and Azithromycin (15.29 DDD/1,000 patients per day). Gyssens' analysis revealed that most prescriptions fell into categories IIA (33.94%), IVA (29.36%), and V (27.52%). Inaccurate dosage and suboptimal antibiotic selection were the leading causes of irrational antibiotic use. Additionally, 30 pneumonia patients were identified who did not receive antibiotics despite having clinical indications for them. The results of this study emphasize the need for rationalization training in therapy, prescription audits, and strengthening the implementation of clinical guidelines in primary care facilities.
- 30 June 2026
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 9 (2) , 225-234
Open AccessAnalysis of Antibiotic Use in Outpatient Pneumonia Patients at X Blitar Health Center using the Gyssens Method and the Defined Daily Dose
Pneumonia is a respiratory infection that remains a public health problem and requires appropriate antibiotic therapy. However, irrational use of antibiotics has the potential to increase resistance and worsen patient clinical outcomes. This study aims to analyze antibiotic use among outpatient patients with pneumonia at the X Blitar Health Center using the Defined Daily Dose (DDD) and Gyssens methods. This study employed a cross-sectional approach, utilizing secondary data from 109 medical records and prescriptions for pneumonia patients (ICD-10 codes J12-J18) from February 2024 to May 2025. Quantitative analysis was conducted using the DDD per 1,000 patients per day method, while qualitative analysis of prescriptions was performed using the Gyssens method. The results showed that Amoxicillin (J01CA04) was the most widely used antibiotic, namely 232.42 DDD/1,000 patients per day, followed by Cefadroxil (87.04 DDD/1,000 patients per day), Ciprofoxacin (18.35 DDD/1,000 patients per day), and Azithromycin (15.29 DDD/1,000 patients per day). Gyssens' analysis revealed that most prescriptions fell into categories IIA (33.94%), IVA (29.36%), and V (27.52%). Inaccurate dosage and suboptimal antibiotic selection were the leading causes of irrational antibiotic use. Additionally, 30 pneumonia patients were identified who did not receive antibiotics despite having clinical indications for them. The results of this study emphasize the need for rationalization training in therapy, prescription audits, and strengthening the implementation of clinical guidelines in primary care facilities.
- Open Access
Pharmacological Profiles and Recovery Predictors in Severe COVID-19
This study analyses the pharmacological profiles of medications administered to critically ill COVID-19 patients to evaluate their efficacy regarding recovery rates and duration of hospitalization. The results demonstrate a significant difference in clinical outcomes. While the administration of Ceftazidime, Ceftriaxone, and Oseltamivir was associated with negative survival trends, Dexamethasone and Favipiravir were associated with a fourfold higher probability of survival in severe cases. Notably, no pharmacological intervention significantly reduced the length of hospital stay; instead, recovery duration was primarily influenced by comorbidities such as obesity, cardiovascular disease, and diabetes. Furthermore, age and preexisting physiological conditions remained primary predictors of mortality. Observational analysis in our study for drug repurposing identified Amikacin, Remdesivir, and Rivaroxaban as potential therapeutic candidates. However, Dexamethasone was identified as the most effective treatment for recovery, likely due to a molecular structure with high potential binding affinity to the SARS-CoV-2 virus. These findings suggest that while specific repurposed drugs offer measurable benefits, patient history remains a critical determinant of outcomes, highlighting the necessity for further research to refine therapies against emerging viral pathogens.
Open AccessPharmacological Profiles and Recovery Predictors in Severe COVID-19
This study analyses the pharmacological profiles of medications administered to critically ill COVID-19 patients to evaluate their efficacy regarding recovery rates and duration of hospitalization. The results demonstrate a significant difference in clinical outcomes. While the administration of Ceftazidime, Ceftriaxone, and Oseltamivir was associated with negative survival trends, Dexamethasone and Favipiravir were associated with a fourfold higher probability of survival in severe cases. Notably, no pharmacological intervention significantly reduced the length of hospital stay; instead, recovery duration was primarily influenced by comorbidities such as obesity, cardiovascular disease, and diabetes. Furthermore, age and preexisting physiological conditions remained primary predictors of mortality. Observational analysis in our study for drug repurposing identified Amikacin, Remdesivir, and Rivaroxaban as potential therapeutic candidates. However, Dexamethasone was identified as the most effective treatment for recovery, likely due to a molecular structure with high potential binding affinity to the SARS-CoV-2 virus. These findings suggest that while specific repurposed drugs offer measurable benefits, patient history remains a critical determinant of outcomes, highlighting the necessity for further research to refine therapies against emerging viral pathogens.
- Open Access
- 9 May 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (5) , 1080
Quantifying the Silent Selection Pressure: Antimicrobial Stewardship and Gut Microbiome Integrity in the NICU and PICU
Background: Antimicrobial stewardship in Neonatal (NICU) and Pediatric Intensive Care Units (PICUs) is complicated by rapid physiological maturation and the high vulnerability of the developing gut microbiome. Traditional metrics fails to capture the true utilization density of antibiotics in these settings. This study evaluated antimicrobial consumption patterns and alignment with the WHO AWaRe framework in two Indonesian hospitals and its impact towards patients’ length of stay. Methods: A retrospective multicenter study was conducted at a public hospital (Haji Hospital) and a private university hospital (HU Hospital) across 2024–2025. The study population includes all admitted patients (n = 315 in NICU and n = 12 in PICU) to calculate utilization density. Consumption was quantified using Defined Daily Dose (DDD)/100 bed-days, and qualitative assessment was performed using the WHO AWaRe classification. Results: Generalized linear modeling revealed that appropriate antibiotic therapy was significantly associated with a 17% reduction in hospital length of stay (β = −0.187, p = 0.035). At HU Hospital, PICU exhibited a seven-fold higher antimicrobial density (37.56 DDD/100) compared to NICU (5.22 DDD/100). At Haji Hospital, NICU density was 4.95 DDD/100 bed-days. Weight-normalized simulations revealed weight-based dosing disparity with low absolute DDD values in neonates mask a significant biological burden and intense selection pressure on the gut resistome due to immature renal clearance. While Haji Hospital maintained high “Access” category adherence (92.21%), HU Hospital’s PICU showed a high reliance on “Watch” agents (71.27%), specifically Ceftriaxone and Meropenem, which are known drivers of multidrug resistance. Conclusions: Low absolute dosing in neonates does not equate to low therapeutic density or reduced environmental pressure. The heavy use of broad-spectrum agents in the PICU acts as a primary driver for microbiome disruption. To mitigate the emergence of multidrug-resistant organisms, stewardship must transition from adult-indexed metrics (DDD) to more precise measures like Days of Therapy (DOT) and prioritize “Access” protocols to preserve microbiome integrity.
- 9 May 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (5) , 1080
Open AccessQuantifying the Silent Selection Pressure: Antimicrobial Stewardship and Gut Microbiome Integrity in the NICU and PICU
Background: Antimicrobial stewardship in Neonatal (NICU) and Pediatric Intensive Care Units (PICUs) is complicated by rapid physiological maturation and the high vulnerability of the developing gut microbiome. Traditional metrics fails to capture the true utilization density of antibiotics in these settings. This study evaluated antimicrobial consumption patterns and alignment with the WHO AWaRe framework in two Indonesian hospitals and its impact towards patients’ length of stay. Methods: A retrospective multicenter study was conducted at a public hospital (Haji Hospital) and a private university hospital (HU Hospital) across 2024–2025. The study population includes all admitted patients (n = 315 in NICU and n = 12 in PICU) to calculate utilization density. Consumption was quantified using Defined Daily Dose (DDD)/100 bed-days, and qualitative assessment was performed using the WHO AWaRe classification. Results: Generalized linear modeling revealed that appropriate antibiotic therapy was significantly associated with a 17% reduction in hospital length of stay (β = −0.187, p = 0.035). At HU Hospital, PICU exhibited a seven-fold higher antimicrobial density (37.56 DDD/100) compared to NICU (5.22 DDD/100). At Haji Hospital, NICU density was 4.95 DDD/100 bed-days. Weight-normalized simulations revealed weight-based dosing disparity with low absolute DDD values in neonates mask a significant biological burden and intense selection pressure on the gut resistome due to immature renal clearance. While Haji Hospital maintained high “Access” category adherence (92.21%), HU Hospital’s PICU showed a high reliance on “Watch” agents (71.27%), specifically Ceftriaxone and Meropenem, which are known drivers of multidrug resistance. Conclusions: Low absolute dosing in neonates does not equate to low therapeutic density or reduced environmental pressure. The heavy use of broad-spectrum agents in the PICU acts as a primary driver for microbiome disruption. To mitigate the emergence of multidrug-resistant organisms, stewardship must transition from adult-indexed metrics (DDD) to more precise measures like Days of Therapy (DOT) and prioritize “Access” protocols to preserve microbiome integrity.
- Open Access
- 6 May 2026
- Published by Universitas Indonesia Maju (UIMA) in Jurnal Ilmiah Ilmu Keperawatan Indonesia
- Vol. 16 (02) , 237-249
Structured Health Education to Improve Medication Adherence Among Patients with Pulmonary Tuberculosis: A Systematic Review
Background: Medication adherence is essential to successful pulmonary tuberculosis treatment. Previous reviews have often combined education with other adherence strategies, leaving its specific contribution uncertain. Objective: To synthesize evidence on structured health education and medication adherence and to appraise the methodological quality of the included studies. Methods: This PRISMA 2020 review searched PubMed and Scopus as primary databases and Google Scholar as a supplementary source for studies published from January 2015 to March 2025. Two reviewers independently screened studies and used design-specific JBI appraisal tools. Fifteen studies were synthesized narratively using SWiM guidance. Results: Counseling, printed and audiovisual materials, supportive education, and digital education generally improved adherence-related outcomes, particularly when interventions were repeated, culturally adapted, interactive, and linked to follow-up. However, most studies were small and non-randomized, used self-reported adherence, and had short follow-up. International trials also showed that digital monitoring alone may not improve clinical outcomes without timely individualized support. Conclusion: Structured health education is a useful component of adherence support but is not sufficient alone to ensure treatment completion. Programs should combine standardized education with individualized follow-up, adverse-effect management, and social support. Rigorous multicenter trials using standardized adherence and treatment outcomes are needed.
- 6 May 2026
- Published by Universitas Indonesia Maju (UIMA) in Jurnal Ilmiah Ilmu Keperawatan Indonesia
- Vol. 16 (02) , 237-249
Open AccessStructured Health Education to Improve Medication Adherence Among Patients with Pulmonary Tuberculosis: A Systematic Review
Background: Medication adherence is essential to successful pulmonary tuberculosis treatment. Previous reviews have often combined education with other adherence strategies, leaving its specific contribution uncertain. Objective: To synthesize evidence on structured health education and medication adherence and to appraise the methodological quality of the included studies. Methods: This PRISMA 2020 review searched PubMed and Scopus as primary databases and Google Scholar as a supplementary source for studies published from January 2015 to March 2025. Two reviewers independently screened studies and used design-specific JBI appraisal tools. Fifteen studies were synthesized narratively using SWiM guidance. Results: Counseling, printed and audiovisual materials, supportive education, and digital education generally improved adherence-related outcomes, particularly when interventions were repeated, culturally adapted, interactive, and linked to follow-up. However, most studies were small and non-randomized, used self-reported adherence, and had short follow-up. International trials also showed that digital monitoring alone may not improve clinical outcomes without timely individualized support. Conclusion: Structured health education is a useful component of adherence support but is not sufficient alone to ensure treatment completion. Programs should combine standardized education with individualized follow-up, adverse-effect management, and social support. Rigorous multicenter trials using standardized adherence and treatment outcomes are needed.
- Open Access
- 29 April 2026
- Published by Pensoft Publishers in Pharmacia
- Vol. 73, e172041
Drug-related problems of antibiotics in outpatients’ settings: a scoping review
Antibiotic use in outpatient settings accounts for the majority of overall antibiotic consumption, yet inappropriate prescribing and drug-related problems (DRPs) remain prevalent and underreported. Conducting a scoping review on antibiotic-related DRPs in outpatients is essential to comprehensively map existing evidence, identify gaps, and inform targeted interventions aimed at optimizing antibiotic use and improving patient safety. The review was conducted following the five-stage methodology developed by Arksey and O’Malley, with studies identified through a PubMed database search. Of the 400 studies retrieved, 22 met the inclusion criteria. The most frequently prescribed antibiotic classes for outpatients were penicillins, macrolides, fluoroquinolones, tetracyclines, and cephalosporins. Commonly reported antibiotic-related DRPs included inappropriate dose and frequency, incorrect duration of therapy, lack of indication for therapy, non-adherence to guideline-recommended treatment, absence of therapy despite indication, potential drug interactions, and adverse drug reactions. Targeted outpatient antimicrobial stewardship is urgently needed to optimize antibiotic use and reduce resistance.
- 29 April 2026
- Published by Pensoft Publishers in Pharmacia
- Vol. 73, e172041
Open AccessDrug-related problems of antibiotics in outpatients’ settings: a scoping review
Antibiotic use in outpatient settings accounts for the majority of overall antibiotic consumption, yet inappropriate prescribing and drug-related problems (DRPs) remain prevalent and underreported. Conducting a scoping review on antibiotic-related DRPs in outpatients is essential to comprehensively map existing evidence, identify gaps, and inform targeted interventions aimed at optimizing antibiotic use and improving patient safety. The review was conducted following the five-stage methodology developed by Arksey and O’Malley, with studies identified through a PubMed database search. Of the 400 studies retrieved, 22 met the inclusion criteria. The most frequently prescribed antibiotic classes for outpatients were penicillins, macrolides, fluoroquinolones, tetracyclines, and cephalosporins. Commonly reported antibiotic-related DRPs included inappropriate dose and frequency, incorrect duration of therapy, lack of indication for therapy, non-adherence to guideline-recommended treatment, absence of therapy despite indication, potential drug interactions, and adverse drug reactions. Targeted outpatient antimicrobial stewardship is urgently needed to optimize antibiotic use and reduce resistance.
- Open Access
- 25 March 2026
- Published by Universitas Mataram in Jurnal Penelitian Pendidikan IPA
- Vol. 12 (3) , 116-122
Effectiveness of Stalevo Drug Usage in Parkinson's Patients: A Narrative Review
Parkinson's Disease (PD) is a neurodegenerative disorder that affects patients' quality of life, with primary motor symptoms such as tremor, muscle rigidity, and bradykinesia. Levodopa is the mainstay of PD therapy, but approximately 80% of patients experience motor complications, such as motor fluctuations and "wearing-off" after several years of therapy. This study evaluates the efficacy, safety, and rational use of Stalevo (levodopa, carbidopa, and entacapone) in managing motor complications and "wearing-off" phenomena in patients with Parkinson's Disease (PD). This research was conducted as a narrative review to provide a recent evidence-based synthesis of the efficacy and safety of Stalevo. Methods included a search of articles in PubMed, ScienceDirect, and Google Scholar published between 2015 and 2025 using the keywords "Stalevo" and "Parkinson's disease." The study revealed that Stalevo was effective in prolonging the duration of levodopa's effect, reducing the required levodopa dose, and improving patients' quality of life, particularly in patients with motor fluctuations. Although side effects such as dyskinesia and diarrhea may occur, Stalevo's overall safety profile is well-received. Stalevo is a cost-effective, evidence-based intervention for intermediate-to-advanced PD. Rational use requires precise patient selection and monitoring for dopaminergic side effects, such as dyskinesia and diarrhea, to optimize quality of life and ensure patient safety.
- 25 March 2026
- Published by Universitas Mataram in Jurnal Penelitian Pendidikan IPA
- Vol. 12 (3) , 116-122
Open AccessEffectiveness of Stalevo Drug Usage in Parkinson's Patients: A Narrative Review
Parkinson's Disease (PD) is a neurodegenerative disorder that affects patients' quality of life, with primary motor symptoms such as tremor, muscle rigidity, and bradykinesia. Levodopa is the mainstay of PD therapy, but approximately 80% of patients experience motor complications, such as motor fluctuations and "wearing-off" after several years of therapy. This study evaluates the efficacy, safety, and rational use of Stalevo (levodopa, carbidopa, and entacapone) in managing motor complications and "wearing-off" phenomena in patients with Parkinson's Disease (PD). This research was conducted as a narrative review to provide a recent evidence-based synthesis of the efficacy and safety of Stalevo. Methods included a search of articles in PubMed, ScienceDirect, and Google Scholar published between 2015 and 2025 using the keywords "Stalevo" and "Parkinson's disease." The study revealed that Stalevo was effective in prolonging the duration of levodopa's effect, reducing the required levodopa dose, and improving patients' quality of life, particularly in patients with motor fluctuations. Although side effects such as dyskinesia and diarrhea may occur, Stalevo's overall safety profile is well-received. Stalevo is a cost-effective, evidence-based intervention for intermediate-to-advanced PD. Rational use requires precise patient selection and monitoring for dopaminergic side effects, such as dyskinesia and diarrhea, to optimize quality of life and ensure patient safety.
- Open Access
- 4 January 2026
- Published by Poltekkes Kemenkes Yogyakarta in Jurnal Teknologi Laboratorium
- Vol. 15 (1) , 87-95
Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Associated with Paracetamol in a Patient with Diabetes Mellitus
Paracetamol is an over-the-counter medication widely used for the management of fever and pain, resulting in a continuous increase in its consumption. Although generally considered safe and well tolerated, paracetamol may, in rare cases, cause severe and life-threatening adverse reactions, including Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). SJS/TEN is a severe drug reaction associated with high morbidity and mortality. We report a case of paracetamol-induced SJS/TEN in a patient with diabetes mellitus. The diagnosis was established based on clinical manifestations and a history of drug exposure. The patient was managed with supportive and pharmacological therapy under close monitoring, including careful glycemic control. This case report highlights the importance of vigilance for severe adverse drug reactions, even when commonly perceived safe medications are used.
- 4 January 2026
- Published by Poltekkes Kemenkes Yogyakarta in Jurnal Teknologi Laboratorium
- Vol. 15 (1) , 87-95
Open AccessStevens–Johnson Syndrome/Toxic Epidermal Necrolysis Associated with Paracetamol in a Patient with Diabetes Mellitus
Paracetamol is an over-the-counter medication widely used for the management of fever and pain, resulting in a continuous increase in its consumption. Although generally considered safe and well tolerated, paracetamol may, in rare cases, cause severe and life-threatening adverse reactions, including Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). SJS/TEN is a severe drug reaction associated with high morbidity and mortality. We report a case of paracetamol-induced SJS/TEN in a patient with diabetes mellitus. The diagnosis was established based on clinical manifestations and a history of drug exposure. The patient was managed with supportive and pharmacological therapy under close monitoring, including careful glycemic control. This case report highlights the importance of vigilance for severe adverse drug reactions, even when commonly perceived safe medications are used.
- Open Access
- 4 January 2026
- Published by Poltekkes Kemenkes Yogyakarta in Jurnal Teknologi Laboratorium
- Vol. 15 (1) , 81-86
Handling Diabetic patients with septic shock condition, AE-COPD, and HAP pneumonia given fluconazole infusion: A case report
Chronic obstructive pulmonary disease (COPD) is a disease characterized by abnormalities in ventilation, including disturbances in the airflow channel. In case this patient is 58 years old with a diagnosis of chronic obstructive pulmonary disease, acute exacerbation (COPD AE), Heart Failure (HF), Coronary Artery Disease (CAD), Hypokalemia, Hypoalbumin. When treated in the intensive care unit (ICU) patient experiencing HAP pneumonia and septic condition, with blood sugar at 324, and use insulin later in an empirical patient treated with antifungal Fluconazole infusion, from the drugs used, researchers need to examine whether fluconazole and insulin are used in the therapy of septic conditions with diabetes. After conducting a literature review of the use of fluconazole infusion and insulin in patients with septic condition cases, things This done to prevent the occurrence of death in patients treated in the ICU. Fluconazole and insulin in the treatment of ICU patients with septic conditions have an appropriate level for preventing death.
- 4 January 2026
- Published by Poltekkes Kemenkes Yogyakarta in Jurnal Teknologi Laboratorium
- Vol. 15 (1) , 81-86
Open AccessHandling Diabetic patients with septic shock condition, AE-COPD, and HAP pneumonia given fluconazole infusion: A case report
Chronic obstructive pulmonary disease (COPD) is a disease characterized by abnormalities in ventilation, including disturbances in the airflow channel. In case this patient is 58 years old with a diagnosis of chronic obstructive pulmonary disease, acute exacerbation (COPD AE), Heart Failure (HF), Coronary Artery Disease (CAD), Hypokalemia, Hypoalbumin. When treated in the intensive care unit (ICU) patient experiencing HAP pneumonia and septic condition, with blood sugar at 324, and use insulin later in an empirical patient treated with antifungal Fluconazole infusion, from the drugs used, researchers need to examine whether fluconazole and insulin are used in the therapy of septic conditions with diabetes. After conducting a literature review of the use of fluconazole infusion and insulin in patients with septic condition cases, things This done to prevent the occurrence of death in patients treated in the ICU. Fluconazole and insulin in the treatment of ICU patients with septic conditions have an appropriate level for preventing death.
- Open Access
- 31 December 2025
- Published by University of Surabaya in MPI (Media Pharmaceutica Indonesiana)
- Vol. 7 (2) , 138-147
Evaluasi Penggunaan Antibiotik Profilaksis Klasifikasi Access pada Pasien Bedah Obstetri-Ginekologi (Obgyn)
Penggunaan antibiotik yang tidak tepat dan berlebih merupakan penyebab utama resistensi antibiotik. Unit bedah merupakan salah satu unit dengan pemakaian antibiotik yang tinggi, salah satunya adalah jenis bedah Obstetri-Ginekologi (obgyn). Pemerintah telah menetapkan indikator mutu nasional dan mewajibkan seluruh rumah sakit untuk menerapkan Program Penatagunaan Antibiotik (antibiotics stewardship) dengan mengelompokkan antibiotik dalam kategori AWaRe : Access, Watch dan Reserve. Evaluasi penggunaan antibiotik merupakan salah satu indikator mutu program pengendalian resistensi antibiotik. Penelitian ini bertujuan menganalisis pola penggunaan antibiotik profilaksis pada pasien Obstetri-Ginekologi (obgyn) dengan metode Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) dan Drug Utilization (DU) 90%, serta mengevaluasi kesesuaian berdasarkan Pedoman Penggunaan Antibiotik (PPAB) dan Formularium Nasional (FORNAS). Studi observasional retrospektif dilakukan pada 118 pasien Obgyn di sebuah rumah sakit di Surabaya selama Mei- Juni 2024. Hasil menunjukkan 100% pasien menerima antibiotik profilaksis dengan total 55,51 DDD/100 hari rawat. Penggunaan antibiotik didominasi kategori Access (54,5%), namun Ceftriaxone (Watch) paling sering digunakan (16,25 DDD/100 hari rawat). Analisis DU 90% mengidentifikasi empat jenis antibiotik yang diurutkan dari persentase terbanyak: Ceftriaxone (29,28%), Metronidazole (26,48%), Cefazolin (26,26%), dan Cefixime (14,30%). Evaluasi kepatuhan PPAB menunjukkan kesesuaian jenis dan dosis (100%) tinggi, tetapi kesesuaian waktu penyuntikan (46,7%) dan durasi pemberian (75,6%) rendah. Inappropriate and excessive use of antibiotics is the main cause of antibiotic resistance. The surgical unit is one of the sections with high antibiotic use, one of which is the Obstetrics-Gynecology (obgyn) surgical procedure. The government has set national quality indicators and requires all hospitals to implement an Antibiotics Stewardship program by grouping antibiotics into the AWaRe categories: Access, Watch, and Reserve. Evaluation of antibiotic use is one of the quality indicators of the antibiotic resistance control program. This study aims to analyze the pattern of prophylactic antibiotic use in Obstetrics-Gynecology (obgyn) patients using the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) and Drug Utilization (DU) 90% methods and evaluate the suitability based on the Antibiotic Use Guidelines (PPAB) and National Formulary (FORNAS). A retrospective observational study was conducted on 118 patients at a hospital in Surabaya in May-June 2024. The results showed that 100% of patients received prophylactic antibiotics with 55.51 DDD/100 bed-days. Antibiotic use was dominated by the Access group (54.5%), but Ceftriaxone (Watch) was the most frequently used 16.25 DDD/100 bed-days. DU 90% analysis identified four main antibiotics: Ceftriaxone (29.28%), Metronidazole (26.48%), Cefazolin (26.26%), and Cefixime (14.30%). PPAB compliance evaluation showed the appropriate type and dose (100%) high, but time (46.7%) and duration of administration (75.6%) low.
- 31 December 2025
- Published by University of Surabaya in MPI (Media Pharmaceutica Indonesiana)
- Vol. 7 (2) , 138-147
Open AccessEvaluasi Penggunaan Antibiotik Profilaksis Klasifikasi Access pada Pasien Bedah Obstetri-Ginekologi (Obgyn)
Penggunaan antibiotik yang tidak tepat dan berlebih merupakan penyebab utama resistensi antibiotik. Unit bedah merupakan salah satu unit dengan pemakaian antibiotik yang tinggi, salah satunya adalah jenis bedah Obstetri-Ginekologi (obgyn). Pemerintah telah menetapkan indikator mutu nasional dan mewajibkan seluruh rumah sakit untuk menerapkan Program Penatagunaan Antibiotik (antibiotics stewardship) dengan mengelompokkan antibiotik dalam kategori AWaRe : Access, Watch dan Reserve. Evaluasi penggunaan antibiotik merupakan salah satu indikator mutu program pengendalian resistensi antibiotik. Penelitian ini bertujuan menganalisis pola penggunaan antibiotik profilaksis pada pasien Obstetri-Ginekologi (obgyn) dengan metode Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) dan Drug Utilization (DU) 90%, serta mengevaluasi kesesuaian berdasarkan Pedoman Penggunaan Antibiotik (PPAB) dan Formularium Nasional (FORNAS). Studi observasional retrospektif dilakukan pada 118 pasien Obgyn di sebuah rumah sakit di Surabaya selama Mei- Juni 2024. Hasil menunjukkan 100% pasien menerima antibiotik profilaksis dengan total 55,51 DDD/100 hari rawat. Penggunaan antibiotik didominasi kategori Access (54,5%), namun Ceftriaxone (Watch) paling sering digunakan (16,25 DDD/100 hari rawat). Analisis DU 90% mengidentifikasi empat jenis antibiotik yang diurutkan dari persentase terbanyak: Ceftriaxone (29,28%), Metronidazole (26,48%), Cefazolin (26,26%), dan Cefixime (14,30%). Evaluasi kepatuhan PPAB menunjukkan kesesuaian jenis dan dosis (100%) tinggi, tetapi kesesuaian waktu penyuntikan (46,7%) dan durasi pemberian (75,6%) rendah. Inappropriate and excessive use of antibiotics is the main cause of antibiotic resistance. The surgical unit is one of the sections with high antibiotic use, one of which is the Obstetrics-Gynecology (obgyn) surgical procedure. The government has set national quality indicators and requires all hospitals to implement an Antibiotics Stewardship program by grouping antibiotics into the AWaRe categories: Access, Watch, and Reserve. Evaluation of antibiotic use is one of the quality indicators of the antibiotic resistance control program. This study aims to analyze the pattern of prophylactic antibiotic use in Obstetrics-Gynecology (obgyn) patients using the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) and Drug Utilization (DU) 90% methods and evaluate the suitability based on the Antibiotic Use Guidelines (PPAB) and National Formulary (FORNAS). A retrospective observational study was conducted on 118 patients at a hospital in Surabaya in May-June 2024. The results showed that 100% of patients received prophylactic antibiotics with 55.51 DDD/100 bed-days. Antibiotic use was dominated by the Access group (54.5%), but Ceftriaxone (Watch) was the most frequently used 16.25 DDD/100 bed-days. DU 90% analysis identified four main antibiotics: Ceftriaxone (29.28%), Metronidazole (26.48%), Cefazolin (26.26%), and Cefixime (14.30%). PPAB compliance evaluation showed the appropriate type and dose (100%) high, but time (46.7%) and duration of administration (75.6%) low.
- Open Access
- 25 December 2025
- Published by Indonesian Journal of Clinical Pharmacy in Indonesian Journal of Clinical Pharmacy
- Vol. 14 (3)
Antibiotics Stewardship in Cesarean Section at a Public Hospital in Surabaya, Indonesia
Cesarean section (CS) is a procedure performed to save the mother and fetus through an incision in the mother’s abdomen and uterus. The high rate of CS in Indonesia correlates with the risk of surgical site infections (SSI), making the use of prophylactic antibiotics important. The use of antibiotics has health impacts on the community, one of which is antibiotic resistance. This study aims to determine antibiotic usage patterns and their compliance with the National Formulary and the Antimicrobial Stewardship Program (PPRA), and the profile of mothers who experience SSI at a public hospital in Surabaya. This retrospective observational quantitative study used medical record data from CS patients from January to June 2024, and the data were analyzed using descriptive statistics and Defined Daily Dose (DDD) methodology to evaluate antibiotic utilization. The results showed cefazolin 2 grams was the most widely used antibiotic (88.64%) with a DDD/100 bed days value of 14.10. Compliance of antibiotic usage patterns with the Antimicrobial Use Guideline (PPAB) reached 88.64%. SSI occurred in 1.31% of patients, especially in pregnancies of more than 2 times. The use of antibiotics at a public hospital in Surabaya is the rational use of antibiotics, the incidence of SSI is smaller than the established standard of 1.5%.
- 25 December 2025
- Published by Indonesian Journal of Clinical Pharmacy in Indonesian Journal of Clinical Pharmacy
- Vol. 14 (3)
Open AccessAntibiotics Stewardship in Cesarean Section at a Public Hospital in Surabaya, Indonesia
Cesarean section (CS) is a procedure performed to save the mother and fetus through an incision in the mother’s abdomen and uterus. The high rate of CS in Indonesia correlates with the risk of surgical site infections (SSI), making the use of prophylactic antibiotics important. The use of antibiotics has health impacts on the community, one of which is antibiotic resistance. This study aims to determine antibiotic usage patterns and their compliance with the National Formulary and the Antimicrobial Stewardship Program (PPRA), and the profile of mothers who experience SSI at a public hospital in Surabaya. This retrospective observational quantitative study used medical record data from CS patients from January to June 2024, and the data were analyzed using descriptive statistics and Defined Daily Dose (DDD) methodology to evaluate antibiotic utilization. The results showed cefazolin 2 grams was the most widely used antibiotic (88.64%) with a DDD/100 bed days value of 14.10. Compliance of antibiotic usage patterns with the Antimicrobial Use Guideline (PPAB) reached 88.64%. SSI occurred in 1.31% of patients, especially in pregnancies of more than 2 times. The use of antibiotics at a public hospital in Surabaya is the rational use of antibiotics, the incidence of SSI is smaller than the established standard of 1.5%.